NEFL and Alzheimer disease: We found that higher number of lobar CMBs in the AD patients were significantly associated with lower amount of the smaller peptides Aβ1-38 and higher amount of NFL, although Aβ1-40, Aβ1-42, P-Tau and T-Tau have been reported (51, 52).